These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. van Coevorden AM, Kamphof WG, van Sonderen E, Bruynzeel DP, Coenraads PJ. Arch Dermatol; 2004 Dec; 140(12):1463-6. PubMed ID: 15611423 [Abstract] [Full Text] [Related]
6. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. Katugampola RP, Hongbo Y, Finlay AY. Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990 [Abstract] [Full Text] [Related]
7. Measuring atopic eczema severity visually: which variables are most important to patients? Charman CR, Venn AJ, Williams H. Arch Dermatol; 2005 Sep; 141(9):1146-51; discussion 1151. PubMed ID: 16172312 [Abstract] [Full Text] [Related]
9. Skin scar preconceptions must be challenged: importance of self-perception in skin scarring. Brown BC, Moss TP, McGrouther DA, Bayat A. J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1022-9. PubMed ID: 19501559 [Abstract] [Full Text] [Related]
10. The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability. Held E, Skoet R, Johansen JD, Agner T. Br J Dermatol; 2005 Feb; 152(2):302-7. PubMed ID: 15727643 [Abstract] [Full Text] [Related]
11. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score. Beattie PE, Lewis-Jones MS. Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397 [Abstract] [Full Text] [Related]
12. Measurement of patient-relevant benefits in the treatment of chronic hand eczema--a novel approach. Blome C, Maares J, Diepgen T, Jeffrustenbach S, Augustin M. Contact Dermatitis; 2009 Jul; 61(1):39-45. PubMed ID: 19659963 [Abstract] [Full Text] [Related]
13. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R. Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [Abstract] [Full Text] [Related]